Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Rofact (May 08, 2009)

Report a Concern
Starting date:
May 08, 2009
Posting date:
May 25, 2009
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-2009A63

Reason

This lot is being recalled because some bottles of Rofact may have been packaged/labeled with clonazepam.

Depth of distribution

Wholesalers and pharmacies in Canada only. No exportation.

Affected products

Rofact

DIN, NPN, DIN-HIM

DIN 00343617

Dosage form

Capsule

Strength

  • 300 mg

Lot or serial number

8K5467

Companies

Recalling Firm
Valeant Canada Ltd.
4787 Levy Street
Montreal Quebec
Canada H4R 2P9
Marketing Authorization Holder
Valeant Canada Ltd.
4787 Levy Street
Montreal Quebec
Canada H4R 2P9